Julie Robillard, a UBC neurology professor and Judy Illes, a UBC neurology professor and Canada Research Chair in Neuroethics, criticized the business of intravenous vitamin therapy, in an op-ed for the Vancouver Sun.
“In our view, besides eroding public trust in the health profession, IV vitamin administration introduces a new dimension of personal risk to health product consumers. As ethicists whose daily work and research is focused on providing constructive guidance for maximizing translation, uptake and understanding of new interventions for the brain and for health care, we have difficulty in balancing the equation of harms versus benefits in this latest example,” they wrote.
